Functional correlates of NT-proBNP reduction in response to chemotherapy in cardiac AL amyloidosis

被引：0
|
作者：
Perlini, S. [1 ]
Salinaro, F. [1 ]
Musca, F. [1 ]
Fracchioni, I. [1 ]
Palladini, G. [1 ,3 ]
Albertini, R. [2 ]
Moratti, R. [2 ]
Palladini, G. [1 ,3 ]
Rapezzi, C. [4 ]
Merlini, G. [3 ]
机构：
[1] Univ Pavia, Med Clin 2, Fondaz IRCCS S Matteo, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Biochem A Castellani, I-27100 Pavia, Italy
[3] Biotechnol Labs IRCCS San Matteo, Ctr Amyloidosis, Pavia, Italy
[4] Univ Hosp Polyclin San Orsola Malpighi, Dept Cardiol, Bologna, Italy
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：722 / 722
页数：1
相关论文
共 50 条
  • [31] Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy
    Lang, Ninian N.
    Badar, Athar A.
    Pettit, Stephen J.
    Templeton, Sheena
    Connelly, Derek T.
    Gardner, Roy S.
    BIOMARKERS IN MEDICINE, 2014, 8 (06) : 797 - 806
  • [32] Clinical utility of the cardiac markers BNP and NT-proBNP
    Buchner, S
    Riegger, G
    Luchner, A
    ACTA MEDICA AUSTRIACA, 2004, 31 (04) : 144 - 151
  • [33] Analytical evaluation of NT-proBNP assay on Cardiac Reader®
    Nachury, C.
    Krebs, M.
    Rozand, I.
    Lefevre, G.
    Sapin, V.
    ANNALES DE BIOLOGIE CLINIQUE, 2008, 66 (03) : 255 - 260
  • [34] Correlation to NT-ProBNP and Remodeling after Cardiac Surgery
    Napchan Boer, Berta Paula
    Campos Vieira, Marcelo Luiz
    Sampaio, Roney Orismar
    Abensur, Henry
    de Oliveira, Alessandra Gomes
    Fernandes, Joao Ricardo
    Grinberg, Max
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 100 (05) : 469 - 475
  • [35] The Cardiac Biomarker NT-proBNP Is Increased in Dogs with Azotemia
    Raffan, E.
    Loureiro, J.
    Dukes-McEwan, J.
    Fonfara, S.
    James, R.
    Swift, S.
    Bexfield, N.
    Herrtage, M. E.
    Archer, J.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2009, 23 (06): : 1184 - 1189
  • [36] Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronisation therapy
    Lang, NNNinian Nicholas
    Badar, A. A.
    Pettit, S. J.
    Templeton, S.
    Connelly, D. T.
    Gardner, R. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 52 - 52
  • [37] NT-proBNP and cardiac events in older diabetic patients
    Resl, Michael
    Neuhold, Stephanie
    Riedl, Michaela
    Abrahamian, Heidemarie
    Strunk, Guido
    Prager, Rudolf
    Clodi, Martin
    Huelsmann, Martin
    Luger, Anton
    Pacher, Richard
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2011, 18 (03): : 399 - 405
  • [38] Plasma NT-proBNP as a marker of cardiac allograft vasculopathy
    Arora, S.
    Andreassen, A. K.
    Simonsen, S.
    Endresen, K.
    Skaardal, R.
    Geiran, O.
    Ueland, T.
    Gullestad, L.
    EUROPEAN HEART JOURNAL, 2006, 27 : 267 - 267
  • [39] High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis
    Castiglione, V
    Aimo, A.
    Prontera, C.
    Masotti, S.
    Chubuchny, V
    Genovesi, D.
    Barison, A.
    Nicol, M.
    Cohen-Solal, A.
    Logeart, D.
    Passino, C.
    Emdin, M.
    Vergaro, G.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2112 - 2112
  • [40] The value of NT-proBNP in detecting late cardiotoxicity after chemotherapy
    Bessi, N. Ould
    Ouabdesselam, S.
    El Mehdaoui, M. A.
    Kemache, A.
    Rabahi, L.
    Abib, L.
    Lakhdari, A.
    Benkhedda, S.
    Chikouche, A.
    Abdelkader, B. Ait
    CLINICA CHIMICA ACTA, 2024, 558 : 36 - 36
12345